Traditionally, antinociception has been associated with occupation of opioid receptors exclusively within the spinal cord [1] . Recently, opioid receptors have been discovered on immune cells, sympathetic nerve fibres and peripheral neurones [2, 3] . Animal behavioural studies have demonstrated antinociception after peripheral administration of opioids [4] .
Peripheral effects of opioids may improve regional anaesthesia without centrally mediated side effects. This would clearly be of benefit during brachial plexus anaesthesia, a commonly used anaesthetic technique for upper limb surgery. However, clinical studies have shown results ranging from improved quality of anaesthesia and postoperative analgesia [5] [6] [7] to no effect [8, 9] .
Ineffective opioid activity during brachial plexus anaesthesia may be because of the inability of the opioid to penetrate axonal myelin and the nerve membrane [4] . In this study, alfentanil was chosen as it is highly un-ionized (89 %) at pH 7.4 [10] . Lignocaine is a commonly used short-acting local anaesthetic which may benefit from improvement in duration of action or postoperative analgesia.
Patients and methods
After obtaining local Ethics Committee approval and written, informed consent, we studied 60 patients, ASA I and II, aged 18-70 yr, weighing 50-100 kg. All were unpremedicated and undergoing elective upper limb surgery.
An 18-gauge i.v. cannula was inserted into the contralateral arm. Routine monitoring was used throughout the study. After sterile preparation, axillary brachial plexus block was carried out using a 20-gauge cannula, as described by Hill and Campbell [11] . Loss of resistance to saline was used to locate the axillary sheath. Having found the sheath, the needle was removed, the cannula advanced and secured in place. A length of primed plastic tubing was attached to the cannula and to a syringe. The patients were then allocated randomly to one of two groups using a sealed envelope technique. Group A received alfentanil 10 g/kg body weight made up to 10 ml with 0.9 % saline. Group S received 0.9 % saline 10 ml. These solutions were prepared before use by a colleague who took no further part in the study. All patients received commercially prepared 1.5 % lignocaine with adrenaline 1 in 200 000 to a total dose of 7 mg/kg body weight. The pH of the mixed solutions in each group was measured later using a pH meter.
Sensory and motor observations were performed every 10 min for 30 min after injection by an observer who was unaware of the solution used. Anaesthesia was assessed using response to pinprick on a three-point scale: normal, impaired or absent sensation. The extent of motor block was assessed using hand grip with a modified Bromage scale: normal, impaired or absent motor function [12] . The block was judged overall to be satisfactory if anaesthesia involved at least two peripheral nerve distributions, including one of the following: median, ulnar, radial or musculocutaneous. The use of rescue adjuvants such as nerve blocks, infiltration or sedation was recorded. The return of sensory and motor function and the time to first request for analgesia were noted. A visual analogue pain score was obtained at hourly intervals for 6 h and at 12 and 24 h. Sedation, ventilatory frequency and peripheral oxygen saturation were also noted at these times. Systemic effects such as nausea, vomiting or pruritus were recorded.
In the second part of the study, 10 patients received axillary brachial plexus anaesthesia as described for group A. In addition, 10-ml samples of venous blood were obtained at 30 min, 1, 2, 3 and 4 h after injection. The samples were centrifuged and frozen to -40 ЊC. Plasma concentrations of alfentanil were measured later by a radioimmunoassay technique of sensitivity 2 pg ml 91 and coefficient of variation 7 % [13] .
Advice regarding statistical analysis was obtained from the Department of Statistics at the Queen's University of Belfast. Patient data and characteristics were compared using unpaired Student's t test and Mann-Whitney U test as appropriate. Onset times in the peripheral nerve distributions were categorized as 0-10, 10-20, 20-30 and greater than 30 min. The number of patients in each category was calculated for all peripheral nerve distributions and for motor function. They were compared using the chi-square test. The fact that complete anaesthesia failed to develop in certain peripheral nerve distributions precluded the use of analysis of variance. P : 0.05 was considered statistically significant.
Results
There were 32 patients in group S and 28 patients in group A. The type of surgery included correction of Dupuytren's contracture (57 %), carpel tunnel median nerve decompression (26 %) and others (17 %). There was no significant difference between groups in age, weight, sex or duration of surgery (table 1) .
There was a greater percentage of patients with complete anaesthesia in the median nerve distribution in group A at 30 min after injection (P : 0.05). There was no significant difference between groups in any other peripheral nerve distribution or in motor function ( fig. 1) .
The overall incidence of satisfactory block was 91.7 % and was not significantly different between groups. The use of rescue adjuvants was similar for both groups. The times to return of sensation (P = 0.013) and motor function (P : 0.001) were prolonged significantly in group A compared with group S (table 2). The time to first request for analgesia was similar in both groups.
There was a significant reduction in visual analogue pain scores (VAS) at 3 h in group A (P = 0.019) but not at any other time ( fig. 2 ). There were no significant differences between groups in sedation, peripheral oxygen saturation or ventilatory frequency. Two patients in group A and one patient in group S developed pruritis. One patient in group A developed nausea. Plasma concentrations of alfentanil did not increase significantly. Concentrations were greatest at 30 min after injection, with a decrease over the next few hours ( fig. 3 ).
There was no significant difference in the pH of the anaesthetic solution between group S (4.01) and group A (4.08).
Discussion
Currently, there is significant cytochemical and behavioural evidence for the existence of peripheral opioid receptor sites. These have been demonstrated on sympathetic nerve fibres and primary afferent neurones [3] . In addition, endogenous opioids have been detected in peripheral terminals of sensory nerves [14] . Animal behavioural studies demonstrating peripheral antinociception have almost universally used response latency to pain inflicted on an inflamed paw [4] .
Buprenorphine and morphine have been shown to improve postoperative analgesia after brachial plexus anaesthesia [5] [6] [7] . Faster onset of anaesthesia has been demonstrated in two studies with fentanyl [15, 16] . Other investigators have found no benefit from the addition of morphine or fentanyl [8, 9] . One suggestion for such inconclusive results is that certain opioids may be unable to penetrate layers of myelin [4] . These are particularly numerous on the proximal nerve axons found in the brachial plexus. It was thought that the use of a highly un-ionized opioid such as alfentanil may have facilitated penetration of the nerve sheath. The dose of alfentanil was chosen after a pilot study comparing 0, 5 and 10 g/kg body weight, in which a clinical effect was demonstrated only with 10 g kg
91
. In order to reduce any physical interaction, the alfentanil and lignocaine solutions were not mixed before injection. However, it is possible that acidic commercially prepared lignocaine and adrenaline solutions may alter the ionic equilibrium of alfentanil within the brachial plexus sheath.
Our study demonstrated improvement in the onset of anaesthesia in one peripheral nerve distribution.
Improvement was not seen in any other distribution or in the development of paresis. These findings are therefore unlikely to be clinically important. However, there was a significant prolongation of sensory and motor block. These clinical observations would suggest that alfentanil may have a local anaesthetic action affecting both sensory and motor neurones. We demonstrated that the systemic absorption of alfentanil after injection into to the axillary sheath produces plasma concentrations unlikely to produce clinical effects [17] .
Opioid receptors are thought to produce antinociception in a variety of ways. A local anaesthetic action on the excitability of nerve terminals and the propagation of nerve impulses is thought to be brought about by two distinct mechanisms. The first involves an early decrease in sodium conductance and a delayed decrease in potassium conductance [18] . This effect is not reversed by naloxone and has been demonstrated on peripheral mammalian nerves with fentanyl and sufentanil [19, 20] . Impaired nerve impulse conduction is seen only at high concentrations of opioid (greater than fentanyl 50 g ml 91 ) [19] . The second local anaesthetic action is reversible by naloxone and involves a decrease in sodium conductance alone [18] . This action occurs at lower opioid concentrations and would appear to relate best to the results of our study. It would have been interesting to observe the effects of naloxone in another group of patients. However, there is uncertainty over which route, how much and over what period naloxone should be administered.
Other mechanisms of action of peripheral opioid receptors involve inhibition of release of substance P from peripheral terminals of primary afferent neurones [21] . This effect is unlikely to have played a significant part in our study. The improvement in visual analogue pain score at 3 h is most likely because of prolonged anaesthesia as no improvement was seen after the return of sensation.
It is known that the peripheral effects of opioids are enhanced after inflammation [22] . This may be because of infiltration of immune cells which would produce a delayed analgesic response. There is evidence for the existence of endogenous opioids in a variety of immune cells infiltrating inflamed subcutaneous tissue [23] . An alternative suggestion is that both axonal transport and proliferation or activation of opioid receptors may be enhanced by inflammatory mechanisms [24, 25] . This inflammatory requirement may limit the usefulness of peripheral opioids in acute pain. Furthermore, axonal opioid receptors may be functionally less efficient than those located at peripheral nerve terminals [4] .
In summary, this study has demonstrated prolongation of sensory and motor block suggestive of a local anaesthetic effect. However, the degree of improvement in anaesthesia is unlikely to render this technique clinically useful. In particular, we did not demonstrate a significant improvement in the quality of postoperative analgesia. The absence of a significant clinical effect is in keeping with the theoretical limitations of peripheral axonal administration of opioids in acute pain. 
